Professor Kristine Macartney MBBS, BMedSci, MD, FRACP Kristine Macartney is a paediatrician and infectious disease specialist. She is a medical graduate of the University of NSW and has almost 20 years of experience in vaccinology. She has experience working in the USA at the Children’s Hospital of Philadelphia where she was a founding member of the US Vaccine Education Center. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She is interested in all aspects of vaccine preventable disease research, particularly policy development, vaccine safety and prevention of viral diseases. She is the Senior Editor of The Australian Immunisation Handbook. Kristine has a clinical appointment at The Children’s Hospital at Westmead as a Staff Specialist in Infectious Diseases and Microbiology and a conjoint academic appointment as Associate Professor in the Discipline of Child and Adolescent Health, University of Sydney. Associate Professor Nicholas Wood MBBS, MPH, FRACP, PhD Nicholas Wood is a staff specialist general paediatrician and Associate Professor and Academic Lead (Higher Degree Research) in the Discipline of Child and Adolescent Health at The University of Sydney. He holds an NHMRC Career Development Fellowship. He leads the NSW Immunisation Specialist Service and coordinates the Immunisation Adverse Events Clinic at The Children's Hospital at Westmead. He is a senior investigator on the Primary Health network immunisation Support program. He is interested in maternal and neonatal immunisation, as well as research into vaccine safety, including genetics and long-term outcomes of adverse events following immunisation. Dr Christopher Blyth A/Prof, MBBS(Hons), PhD W. Ast., DCH, FRACP, FRCPA Chris Blyth is a clinical academic and NHMRC Career Development Fellow. He is Associate Professor of Paediatrics with the School of Medicine, University of Western Australia and Research Fellow with Wesfarmers Centre for Vaccines and Infectious Diseases (WCVID; Telethon Kids Institute [TKI], WA). He leads the Department of Paediatric Infectious Diseases at Princess Margaret Hospital and a Clinical Microbiologist with PathWest Laboratory. He has been a sitting member of the Australian Technical Advisory Group on Immunisation (ATAGI) since 2012, deputy chair since 2015 and co-chair since 2018. He has more than fifteen years of experience in conducting clinical paediatric and infectious diseases research focusing on questions relevant to public policy and clinical practice. The majority of his research is in influenza, vaccine-preventable respiratory tract infection, pneumonia, respiratory co-infection, emerging respiratory pathogens and vaccine safety. His PhD evaluated the WA preschool influenza vaccination program and has been instrumental in influencing national influenza policy. He holds a NHMRC Career Development Fellowship which is evaluating influenza and pneumococcal vaccination programs in Australia and PNG. Dr Tom Snelling BMBS, DTM&H, GDipClinEpid, PhD, FRACP Tom Snelling is a paediatric infectious diseases physician at the Perth Children’s Hospital, NHMRC Career Development Fellow and the Director of the Telethon Kids Institute's Wesfarmers Centre of Vaccines & Infectious Diseases. His research addresses the implementation of health policy and clinical practice, in particular the evaluation of vaccination and other public health strategies to minimise the burden of childhood infectious diseases. This work integrates clinical trials with case-control and cohort studies and disease modelling. His current work is investigating how best to prevent and treat gastroenteritis, pneumonia, pertussis and other lower respiratory infections, and congenital rubella. Tom was awarded a Medical Research Future Fund (MRFF) grant from NHMRC 2018 and leads this Bayesian Evidence-Adaptive Trial to optimise management of Cystic Fibrosis. His work has a strong focus on Aboriginal and international child health. He is also investigating the safety of vaccination in early childhood. Dr Nigel Crawford BMBS FRACP MPH PhD Nigel Crawford is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), a vaccine safety and clinical immunisation research group based at Murdoch Children's Research Institute. Having completed his medical undergraduate studies at Flinders University Adelaide, Nigel has a masters of public health from Cardiff University, Wales and a Vaccinology PhD from The University of Melbourne. He is also a general paediatrician and Head of the Immunisation Service at The Royal Children's Hospital and an expert in the vaccination of special risk groups (e.g. immunosuppressed patients) and the clinical evaluation of adverse events following immunisation. Nigel is the co-lead of AEFI CAN. He also has a keen interest in vaccine education, establishing the Clinical Vaccinology Update (held biannually) in 2012 and the Melbourne Vaccine Education Centre in 2014. Nigel is a current member of the Australian Technical and Advisory Group on Immunisation (ATAGI) Professor Paul Effler MD, MPH, FAFPHM Paul Effler received a Doctorate in Medicine from the University of California and a Master of Public Health from the University of Hawaii. Upon completing a residency in Public Health Medicine, Dr Effler served as an Officer in the Epidemic Intelligence Service at the US Centers for Disease Control and Prevention (CDC). In 1994 he became the State Epidemiologist for Hawaii, where he directed the public health response to SARS, dengue fever, measles, and influenza and oversaw Hawaii’s immunisation program. In 2008 Dr Effler moved to Perth where he works in immunisations and communicable disease control. Following experience responding to ebola in West Africa, Dr Effler was appointed to the Steering Committee of the Global Outbreak and Response Network at the World Health Organisation (WHO); he also serves on the Technical Advisory Group for the Asia Pacific Strategy for Emerging Diseases at the WHO Western Pacific Regional Office, is an adjunct Professor at University of Western Australia, and an Associate Editor for the journal Emerging Infectious Diseases at CDC. Professor David Durrheim MBChB, DTM&H, DrPH, MPH&TM, MBChB, FACTM, FAFPHM, FAAHMS Professor David Durrheimis Conjoint Professor of Public Health Medicine, University of Newcastle, and Director - Health Protection, Hunter New England Health. He is a Public Health Physician with an established track record in conducting public health research that has an operational focus and is translational in nature. His ability to use operational research findings to assist local public health programs to improve their surveillance and service delivery has resulted in a number of awards and international recognition. Professor Durrheim is an outspoken advocate for equitable global access to effective public health measures, particularly immunisation. He has been instrumental in developing novel surveillance systems to detect and facilitate response to emerging infectious disease risks and adverse events following immunisation. He has served as an expert adviser and consultant to a number of World Health Organisation (WHO), regional and national health programs in the African and Pacific Regions. He continues to serve on various Strategic Advisory Group of Experts on Immunisation working groups advising the WHO, along with being Chair of the National Polio Elimination Certification Committee and Western Pacific Regional Measles Elimination Verification Commission. Professor Michael Gold MbChB, DCH, MD, FCP, FRACP Professor Michael Gold is a Paediatric Allergist and Immunologist with conjoint positions in the Discipline of Paediatrics, University of Adelaide and is former Medical Unit Head, of the Department of Allergy and Immunology at the Women’s and Children’s Health Network. He has a research and clinical interest in the prevention of food allergy and vaccine safety. He was appointed to the World Health Organisation Global Advisory Committee for Vaccine Safety in 2010 and has been an advisor to the Therapeutic Goods Administration via his appointment to a number of expert advisory groups since 2006. He has been awarded ARC and NHMRC grants as principle investigator for projects that have researched novel methods of safety surveillance including data linkage and m-Health. He has contributed to a number of key WHO guidelines which include a global Adverse Event Following Immunisation surveillance manual, the WHO guideline on causality assessment and has recently led a WHO workgroup to develop a guideline for programme managers on Immunisation stress related responses. Dr Alan Leeb DTM&H, DCH, DFM, FRACGP Dr Alan Leeb grew up in Johannesburg, South Africa where he received his medical training before migrating to Tasmania, Australia in 1986. From there he moved to Perth, Western Australia which he has called home for the past 25 years. He holds qualifications in Tropical Medicine (DTM&H), Paediatrics (DCH) and Family Medicine (DFM). He is also a Fellow of the Royal Australian College of General Practitioners (FRACGP). In addition, Alan holds numerous board and advisory positions across a number of organisations. Alan is the principal General Practitioner (GP) at Illawarra Medical Centre, having first established the practice in 1994. He is also the developer of SmartVax – a national active adverse event surveillance system for immunisation. Alan won the prestigious Royal Australian College of General Practitioners’ Peter Mudge Award in 2014 for his work with SmartVax. Alan has particular interests in paediatrics, immunisation, allergies and primary care research. Professor Jim Buttery MBBS MSc FRACP MD Jim is a paediatric infectious diseases physician and vaccinologist, who trained in Australia and Oxford, UK. He is head of Infection and Immunity, and Director of Research at Monash Children’s Hospital and head of Monash Immunisation, Monash Health, Melbourne, Australia. He is Professor of Paediatric Epidemiology at Monash University. He heads Epidemiology and Signal Investigation for SAEFVIC, the Victorian immunisation safety service. He serves as a member of the Strategic Priority Group of the WHO Global Vaccine Safety Initiative, the Australian Medical Services Advisory Committee, and the TGA Advisory Committee on Vaccines. Jim’s research focuses upon vaccine safety, signal detection systems, infectious disease epidemiology and child health informatics.